Sentences with phrase «for vaccine researchers»

These results may provide new ways for vaccine researchers to target HIV and may influence the design of future HIV vaccines.

Not exact matches

Researchers at Oregon Health & Science University are currently looking for volunteers that can be tested during an upcoming clinical trial for a vaccine that may cure HIV, the virus that causes AIDS.

Researchers have developed a vaccine for preventing allergic reactions to peanuts in laboratory mice.

Armed with that information, the researchers then designed a mutant flu strain that was powerful enough to replicate well but highly susceptible to our body's own ability to control the virus — the ideal ingredients for a vaccine.

The researchers are currently planning a follow - up study which will test whether a flu vaccine is more effective for the elderly when combined with brief use of Losmapimod.

There may also be other applications from this work, they say: Researchers could similarly take other viruses apart in the lab, scour them for important mutations and create vaccines against a plethora of other infections.

But rather than dashing all hopes for an AIDS vaccine, the trial has heartened some researchers, who see new clues in the battle against the fatal illness.

The hunt for a universal flu vaccine, a single shot that would provide lifelong immunity, has been going on for decades, and many teams of researchers have been on the case.

Researchers, including our team at Penn, are using it as a foundation for developing vaccines for other mosquito - borne illnesses like Zika and Dengue.»

This technology could help researchers rapidly generate new peptide drugs to test on a variety of diseases, and it also raises the possibility of easily producing customized cancer vaccines for individual patients.

«Although HPV vaccine has been around for more than a decade, the uptake of the vaccine has been less than ideal in many places, including in high - resource countries such as the United States,» said Silvina Arrossi, PhD, co-chair of the Expert Panel that developed the guideline and an official and researcher at the Instituto Nacional del Cancer in Buenos Aires, Argentina.

Studies that compare flu alterations in multiple people won't immediately tell researchers how to design vaccines, she says, but could point to parts of the virus for further investigation.

Roughly a year after Brazilian doctors and researchers first suspected a link between a spate of alarming birth defects and the Zika virus, a cadre of potential vaccines are now headed for testing in humans.

Yoshihiro Kawaoka of the University of Wisconsin - Madison, lead researcher on the other study, adds that the meeting allowed him and Fouchier to explain their work, including the potential benefits for surveillance of emerging flu strains (Nature 481, 417 - 418; 2012) and for vaccine preparation (Nature 482, 142 - 143; 2012).

Researchers for the past decade have focused on the T cell approach, based on studies showing that monkeys receiving such vaccines against simian immunodeficiency virus, related to HIV, lived longer or had lower viral levels than usual.

Having a readily available oral vaccine for the wolves was a lucky break for the researchers in Ethiopia.

Researchers could then reverse - engineer barcodes for the vaccine, and thus the flu itself, as well as other diseases.

In collaboration with many researchers (graduate students, postdocs, and faculty elsewhere), we have examined the role of cross-immunity on the evolution and dynamics of influenza; the impact of behavioral changes, long periods of infectiousness, variable infectivity, co-infections, prostitution, social networks, and vaccine efficacy on HIV dynamics; the role of exogenous re-infection, variable progression rates, vaccination, public transportation, close and casual contacts on tuberculosis dynamics and control; the impact of life - history vector dynamics on dengue epidemics; and on the identification of time - response scales for epidemics of foot and mouth disease.

Researchers from the University of Zurich and University Hospital Zurich now reveal which factors are responsible for the human body forming such broadly neutralizing HIV antibodies, thereby opening new avenues for the development of an HIV vaccine.

An effective vaccine against the virus that causes genital herpes has evaded researchers for decades.

The genetic code also holds clues to Chlamydia's surface proteins, which Stephens says should give researchers new targets for vaccines, diagnostic tests, and drugs.

A major new finding that will significantly advance efforts to create the world's first antibody - based AIDS vaccine was published today by researchers from the La Jolla Institute for Allergy and Immunology.

One contains the vaccine — for their tests, the researchers used a liquid version of ovalbumin, a constituent of egg whites.

For some researchers the big goal is to bump up the effectiveness of existing vaccines, most of them made from chemically - killed influenza particles or proteins extracted from such particles (see «Anatomy of a killer virus»).

La Jolla Institute scientist Shane Crotty, Ph.D., a respected vaccine researcher and member of one of the nation's top AIDS vaccine consortiums, showed that certain helper T cells are important for triggering a strong antibody response against HIV, the virus that causes AIDS.

The researchers found that in mice, a single injection of 30 millionths of a gram of these mRNAs — a small fraction of the dose used for a typical vaccine — induced a rapid immune response, which protected mice from intravenous exposure to a separate Zika strain two weeks later.

If AIDS is caused by a virus, why has it been impossible for researchers to develop a vaccine after 20 years and millions of dollars spent?

By studying healthy people, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center, part of the NIH, and colleagues from King's College London have created a reference resource for other scientists.

Johns Hopkins Bloomberg School of Public Health researchers say a new candidate vaccine against respiratory syncytial virus (RSV) made with a weakened version of the virus shows great promise at fighting the disease, the leading cause of hospitalization for children under the age of one in the U.S.

And although treatment with rehydration salts and proper food can save lives, researchers have been working for years on a vaccine that could reduce the severity of the disease, especially in developing countries with poor health care and nutrition.

Yale Cancer Center researchers have developed a vaccine strategy that reduces the risk of flu infections in cancer patients at highest risk for influenza.

In a March 2009 study published in Genes and Immunity, researchers at the National Center for Computational Toxicology compared the genetic signatures of 16 people who experienced smallpox vaccine side effects, including fever, rashes and enlarged lymph nodes, to 45 people who did not.

The researchers also tested willingness to pay for a vaccine at various price points.

The researchers» findings have major implications for future vaccine development.

In these countries pneumonia, malaria and diarrhea were the leading causes of death), so to improve survival in these regions the researchers recommended improving the uptake of breastfeeding, providing vaccines for pneumonia, malaria and diarrhea, and improving water and sanitation.

The researchers hope that understanding the level of virus needed for transmission of infection will provide a useful reference point for the development of experimental drugs and vaccines and could be used to inform the endpoints for clinical trials evaluating such interventions.

Cincinnati Cancer Center (CCC) and UC Cancer Institute researchers have found that a vaccine, targeting tumors that produce a certain protein and receptor responsible for communication between cells and the body's immune system, could initiate the immune response to fight cancer.

The researchers studied 4,193 pregnant women; about half of the subjects received a flu vaccine; the other half received a vaccine for meningitis.

Researchers from Southern Medical University in Guangdong, Guangzhou, China, have developed an oral vaccine against Helicobacter pylori, the bacteria responsible for peptic ulcers and some forms of gastric cancer, and have successfully tested it in mice.

An exception to this trend is Dong Pyou Han, a former Iowa State University (ISU) biomedical researcher who last week was sentenced to prison for 57 months — almost 5 years — for falsifying results in HIV vaccine studies he participated in while working under lab head Michael Cho, The Guardian reports.

With this approach if validated for other vaccines, we only need to wait for a week,» says researcher Ali Harandi, who heads the participation of Sahlgrenska Academy and University of Gothenburg in the project.

Medical researchers are working hard to develop effective vaccines and other immunotherapy treatments for pancreatic cancer.

The researchers are planning to test this method to deliver HIV vaccines in nonhuman primates, and they are also working on further developing cancer vaccines, including one for lung cancer.

The researchers found a slight increase in the relative risk of febrile seizure with the MMRV vaccine compared with the MMR+V vaccine — about 1 excess seizure for every 2841 doses administered in the 7 - to 10 - day period after vaccination.

University of Tübingen researchers in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria ® PfSPZ - CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine.

Researchers led by a team at Duke University identified these immunologic variations by studying blood samples collected from people living with HIV by the NIAID - supported Center for HIV / AIDS Vaccine Immunology (CHAVI).

LONDON (Reuters)-- Researchers announced the launch of two big studies in Africa on Thursday to test a new HIV vaccine and a long - acting injectable drug, fuelling hopes for better ways to protect against the virus that causes AIDS.

The researchers are now looking at how ICOS signals can be altered to diminish autoimmune disorders and augmented for more effective vaccine development, and are beginning research on how ICOS signaling may benefit Chimeric Antigen Receptor - T cell (CAR - T) therapies, which involves engineering of patient's own immune cells to recognize and attack their cancers.

The researchers then tested each strain of the virus for susceptibility to two potent and commonly used antibodies in vaccine development experiments for HCV, HC33.4 and AR4A.

Some researchers have argued that lower doses may be slower to kick the immune system into gear, which could cause the vaccine virus to linger in the body for longer and actually increase the risk of some side effects.